This HTML5 document contains 121 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q52811121
rdf:type
wikibase:Item
schema:description
artikulong pang-agham artículo científico publicado en 2016 научни чланак articolo scientifico videnskabelig artikel artikel ilmiah مقالة علمية نشرت في 18 ديسمبر 2016 научна статия vedecký článok 2016年学术文章 2016年學術文章 artigo científico 2016年学术文章 article scientific article scientifique vetenskaplig artikel naučni članak scientific article published on 18 December 2016 bài báo khoa học vitenskapelig artikkel artykuł naukowy наукова стаття, опублікована в грудні 2016 artikull shkencor ১৮ ডিসেম্বর ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2016年學術文章 article científic 2016年學術文章 2016年学术文章 2016年学术文章 scienca artikolo teaduslik artikkel vitskapeleg artikkel artigo científico επιστημονικό άρθρο bilimsel makale 2016年学术文章 scientific article published on 18 December 2016 articol științific 2016년 논문 мақолаи илмӣ 2016 nî lūn-bûn vědecký článek научная статья tieteellinen artikkeli บทความทางวิทยาศาสตร์ 2016年學術文章 artigo científico 2016年学术文章 2016年の論文 wissenschaftlicher Artikel 2016年學術文章 scientific article published on 18 December 2016 artículu científicu სამეცნიერო სტატია מאמר מדעי tudományos cikk научни чланак wetenschappelijk artikel
p:P577
wds:Q52811121-3C3D44FA-6E56-4D8A-A89D-64C23C07DA5A
wdt:P577
2016-12-18T00:00:00Z
p:P407
wds:Q52811121-07CF9FE9-F921-4767-94EF-C22D6944E72E
wdt:P407
wd:Q1860
p:P2093
wds:Q52811121-296BE6FD-DE95-419E-9716-5105CBEF25C5 wds:Q52811121-A09144C8-C6D7-42F4-A1C7-688B5EF94D86 wds:Q52811121-A5E6085A-CD5A-41B2-BE8D-B3A923F8CE31 wds:Q52811121-8E9C44AB-75DA-481E-8020-F70F29775484 wds:Q52811121-737920AA-6672-4182-9935-44F018DBE168 wds:Q52811121-6F55DB0B-1C02-45C4-9038-CC2CF824BAB8 wds:Q52811121-57299D54-2C50-4B53-BAE0-D753B25F37F4 wds:Q52811121-58C81B50-7C58-4FD7-BF48-43EE4CBAEEF7 wds:Q52811121-3058CD82-B737-4AAD-9F4B-235E3853EA99 wds:Q52811121-32D24C8D-D1C6-4781-BF4E-CE6A06639169 wds:Q52811121-F894C1AA-DC00-4F81-88EC-90FAE9AABBFE wds:Q52811121-F4530F30-1E12-4B6D-9273-6E9888D902B9 wds:Q52811121-E85B0990-060E-4DAA-B49A-F5D59586795E wds:Q52811121-D29901B5-938C-49A9-9AE9-2DD95D94EDC8 wds:Q52811121-BCB8F59F-983A-4BF9-80D1-4BB1185CBD38
wdt:P2093
Douglas F Arbetter Yazan Daaboul Shiao-Ping Lu Janet M Leeds Serge Korjian Olga Bandman Russel Hull Adrian F Hernandez C Michael Gibson Alex Gold Alexander T Cohen APEX Investigators Samuel Z Goldhaber Rim Halaby Megan K Yee
rdfs:label
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
skos:prefLabel
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE
schema:name
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
p:P50
wds:Q52811121-68D36B19-8FDA-461E-B58D-987632CF0DF3
wdt:P50
wd:Q62914910
p:P1476
wds:Q52811121-D9101664-5A6F-4CF3-90B6-07567A4C03A8
wdt:P1476
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
p:P304
wds:Q52811121-54495239-168E-4FAA-B682-7C00BC9E8027
wdt:P304
93-100
p:P31
wds:Q52811121-4C1D83FF-924C-4713-812C-FF229146727F
wdt:P31
wd:Q13442814
p:P921
wds:Q52811121-4FAF9D8D-F07C-43EC-B395-386D01787513 wds:Q52811121-E96F7D9F-137F-4DAF-A930-A42FB2C1DF10
wdt:P921
wd:Q9397786 wd:Q4898219
p:P698
wds:Q52811121-945E571C-77C4-4C81-95B5-45E79E11FE58
wdtn:P698
n12:28267480
wdt:P698
28267480
p:P1433
wds:Q52811121-CB6157FF-375F-4B7A-9F21-4F955D36AE1D
wdt:P1433
wd:Q2227156
p:P478
wds:Q52811121-AA1ACB6D-25E0-45C5-8E1A-10D5F5FD9C25
wdt:P478
185
p:P356
wds:Q52811121-78F0FA8B-3CA2-4B49-BCD5-B4E8018BC16C
wdtn:P356
n8:J.AHJ.2016.12.004
wdt:P356
10.1016/J.AHJ.2016.12.004